SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Matthew D. Galsky, Sumanta K. Pal, Simon Chowdhury, Lauren C. Harshman, Simon J. Crabb, Yu-Ning Wong, Evan Y. Yu, Thomas Powles, Erin L. Moshier, Sylvain Ladoire, Syed A. Hussain, Neeraj Agarwal, Ulka N. Vaishampayan, Federica Recine, Dominik Berthold, Andrea Necchi, Christine Theodore, Matthew I. Milowsky, Joaquim Bellmunt, Jonathan E. Rosenberg, Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer, Cancer, 2015, 121, 11
  2. 2
    V. Meyer, A. Flechon, S. Tartas, H. Fassi-Fehri, A. Ruffion, X. Martin, M. Colombel, Impact de la chimiothérapie néoadjuvante sur la prise en charge des tumeurs de vessie infiltrant le muscle, Progrès en Urologie, 2015, 25, 2, 83

    CrossRef

  3. 3
    Guifa Xi, Erik Robinson, Barbara Mania-Farnell, Elio Fausto Vanin, Kyu-Won Shim, Tsurubuchi Takao, Elise Victoria Allender, Chandra Shekhar Mayanil, Marcelo Bento Soares, Dean Ho, Tadanori Tomita, Convection-enhanced delivery of nanodiamond drug delivery platforms for intracranial tumor treatment, Nanomedicine: Nanotechnology, Biology and Medicine, 2014, 10, 2, 381

    CrossRef

  4. 4
    Jong Chul Park, Deborah E. Citrin, Piyush K. Agarwal, Andrea B. Apolo, Multimodal management of muscle-invasive bladder cancer, Current Problems in Cancer, 2014, 38, 3, 80

    CrossRef

  5. 5
    Weiwei Guo, Meng Zheng, Yinan Zhong, Fenghua Meng, Chao Deng, Zhiyuan Zhong, Poly(ethylene oxide)-graft-methotrexate Macromolecular Drugs Conjugating via Aminopteridine Ring Exhibit Potent Anticancer Activity, Chinese Journal of Chemistry, 2014, 32, 1
  6. 6
    Manzoor A. Rather, Bilal A. Bhat, Mushtaq A. Qurishi, Multicomponent phytotherapeutic approach gaining momentum: Is the “one drug to fit all” model breaking down?, Phytomedicine, 2013, 21, 1, 1

    CrossRef

  7. 7
    Christopher M Tully, Gopa Iyer, Dean F Bajorin, Neoadjuvant chemotherapy in bladder cancer, Clinical Investigation, 2013, 3, 10, 991

    CrossRef

  8. 8
    Damien Pouessel, Pierre Mongiat-Artus, Stéphane Culine, Neoadjuvant chemotherapy in muscle-invasive bladder cancer: Ready for prime time?, Critical Reviews in Oncology/Hematology, 2013, 85, 3, 288

    CrossRef

  9. 9
    R.P. Meijer, J.A. Nieuwenhuijzen, W. Meinhardt, A. Bex, H.G. van der Poel, B.W. van Rhijn, J.M. Kerst, A.M. Bergman, E. van Werkhoven, S. Horenblas, Response to induction chemotherapy and surgery in non-organ confined bladder cancer: A single institution experience, European Journal of Surgical Oncology (EJSO), 2013, 39, 4, 365

    CrossRef

  10. 10
    Friederike Klein, Neoadjuvante Blasenkrebstherapie auf evidenzbasierte Füße stellen, Im Focus Onkologie, 2012, 15, 12, 31

    CrossRef